Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
about
Histopathological study of cardiac lesions in methamphetamine poisoning-related deaths.CYP2D6 genetic polymorphisms and their relevance for poisoning due to amfetamines, opioid analgesics and antidepressants.Exposure to Amphetamines Leads to Development of Amphetamine Type Stimulants Associated Cardiomyopathy (ATSAC).Cardiogenic shock after use of fluoroamphetamine confirmed with serum and urine levels.
P2860
Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
@en
Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
@nl
type
label
Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
@en
Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
@nl
prefLabel
Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
@en
Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
@nl
P2093
P2860
P1433
P1476
Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
@en
P2093
D B Diercks
J Southard
M E Sutter
T E Albertson
P2860
P304
P356
10.3109/15563650.2013.818684
P407
P577
2013-07-15T00:00:00Z